- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Financial
Changing attitudes – sustainability, nutrition and wellness
Perspectives on sustainability and wellbeing are changing in response to health and environmental challenges, offering an opportunity to university-linked businesses.
Apr 11, 2019HDI finds Next Big Thing
HDI Global led internet-of-things and insurance incubator Next Big Thing's $13.5m series A round, participating together with Finlab EOS.
Apr 10, 2019SoftBank builds Latin American investment team
SoftBank has tapped three executives to help run its $5bn Latin America-focused fund, with Paulo Passoni and Shu Nyatta to work alongside managing partner André Maciel.
Apr 10, 2019Monzo to put $130m on its books
The deal will double the Orange and Stripe-backed digital bank’s valuation to $2.6bn, making it the second most valuable fintech developer in the UK.
Apr 10, 2019Progressive helps provide $50m for Upstart
The Alphabet and Rakuten-backed lending platform increased its total funding to more than $160m in a round featuring Progressive Investment Company.
Apr 10, 2019Levine leaps to Samsung Catalyst
Scott Levine, a GCV Rising Star in 2018, has departed WarnerMedia Investments in order to set up an office in New York City for Samsung Catalyst Fund.
Apr 10, 2019Branch International breaches series C with $170m
The emerging markets finance provider secured $170m in a round that was co-led by Visa, which is also collaborating with it on a virtual credit card scheme.
Apr 9, 2019Mitsubishi UFJ mints $180m fund
Mitsubishi UFJ Financial Group's MUFG Innovation Partners unit will target Japanese and Southeast Asian fintech startups, and its first portfolio company is Moneytree.
Apr 8, 2019Vestwell gets $30m in series B funding
Goldman Sachs led the pension platform developer's latest round, which included Allianz Life Ventures, Nationwide and BNY Mellon.
Apr 8, 2019Analysis: Fusion Pharma gets $105m in series B
Oncology therapeutics developer Fusion Pharmaceticals closed a $105 round, featuring several corporate investors. The deal forms part of the growing broad oncology space, which has seen much attention from corporate venturers in recent years.
Apr 8, 2019Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


